Previously, we informed about the NANOMET workshop on the OECD Guidance Document (GD) 317 dealing with the aquatic and sediment toxicity testing of nanomaterials. By the end of last week another NANOMET online seminar took place. There, the scope, content and practical use of the testing guideline (TG) 318 was discussed. It particularly focused on…

The next-generation mRNA vaccines developed by BioNTech-Pfizer, and, the colloquially called Moderna vaccine scream innovation. mRNA vaccines are a clever way of tricking the body into producing antibodies against SARS-CoV-2, without actually introducing the whole viral particle, but just a strand of its genetic material (RNA). Once inside the host cells, these mRNA strands are…

Last week we informed about the existing variety of definitions for nanomaterials (NM) among the different EU-regulations. As previously indicated these differences do also have a direct impact on the data to be evaluated under the respective regulation. Together with a selection of NM definitions, this information was previously published by the VdMi. Today, we…

In our many previous blog entries, we have talked about nanomaterial regulation within the EU. In general, nanomaterials and nanoforms are covered within the same meticulous regulatory framework, i.e. the REACH and CLP regulations. After decades of discussions between the EU member states, the European Commission, scientists and other stakeholders, new revisions to the existing…